ParselSMIarocciALGastañaduyMWintersRDMarinoJPMcCoulED. reflux disease and laryngeal neoplasia in nonsmokers and nondrinkers. Otolaryngol Head Neck Surg. 2020:194599820917669. doi:10.1177/0194599820917669
2.
LechienJRAkstLMHamdanAL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg. 2019;160(5):762-782. doi:10.1177/0194599819827488
3.
JaspersenDKuligMLabenzJ, et al. Prevalence of extra- oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003;17:1515-1520.
4.
WangLWangGLiL, et al. Relationship between laryngopharyngeal reflux disease and gastroesophageal reflux disease based on synchronous esophageal and oropharyngeal Dx-pH monitoring. Am J Otolaryngol. 2020;102441. doi:10.1016/j.amjoto.2020.102441
5.
NiuKGuoCTengS, et al. Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation. PLoS One. 2020;15(1):e0227408. doi:10.1371/journal.pone.0227408
